Cas:118469-08-2 1-(fluoromethyl)benzimidazole-2-carbaldehyde manufacturer & supplier

We serve Chemical Name:1-(fluoromethyl)benzimidazole-2-carbaldehyde CAS:118469-08-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

1-(fluoromethyl)benzimidazole-2-carbaldehyde

Chemical Name:1-(fluoromethyl)benzimidazole-2-carbaldehyde
CAS.NO:118469-08-2
Synonyms:1-(Fluoromethyl)-1H-benzo[d]imidazole-2-carbaldehyde;1H-Benzimidazole-2-carboxaldehyde,1-(fluoromethyl)
Molecular Formula:C9H7FN2O
Molecular Weight:178.16300
HS Code:2933990090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:341.9ºC at 760 mmHg
Density:1.3g/cm3
Index of Refraction:1.601
PSA:34.89000
Exact Mass:178.05400
LogP:1.77580

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 1-(Fluoromethyl)-1H-benzo[d]imidazole-2-carbaldehyde chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1H-Benzimidazole-2-carboxaldehyde,1-(fluoromethyl) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1H-Benzimidazole-2-carboxaldehyde,1-(fluoromethyl) Use and application,1-(Fluoromethyl)-1H-benzo[d]imidazole-2-carbaldehyde technical grade,usp/ep/jp grade.


Related News: Over the past twelve months, the collaboration team has worked to optimize its processes for making T cells from iPSCs, and has now shown the production of pure T-lymphocytes consisting of both CD8+ and CD4+ T cells having a global gene expression profile that is highly-similar to primary T cells based on a principal component analysis. 1-(fluoromethyl)benzimidazole-2-carbaldehyde manufacturer Italy and Vietnam included Taiwan in banning flights from China, a move that they announced after the W.H.O. declared the coronavirus outbreak a global health emergency. 1-(fluoromethyl)benzimidazole-2-carbaldehyde supplier Inceptua Medicines Access is a business unit of the Inceptua Group. It offers full access solutions for the design, implementation and delivery of Pre-approval and Medicines Access Programs on behalf of biopharmaceutical companies. 1-(fluoromethyl)benzimidazole-2-carbaldehyde vendor Retrogenix and Resonant Therapeutics, Inc. recently announced they have entered into a non-exclusive strategic partnership to identify the targets of Resonant antibodies directed against the tumor microenvironment. 1-(fluoromethyl)benzimidazole-2-carbaldehyde factory Retrogenix and Resonant Therapeutics, Inc. recently announced they have entered into a non-exclusive strategic partnership to identify the targets of Resonant antibodies directed against the tumor microenvironment.